Semi-Annual Consolidated Statement Of Income

Astellas Pharma Inc. - Filing #7604918

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Semi-annual consolidated statement of income
Statement of income
Net sales
542,568,000,000 JPY
545,553,000,000 JPY
Cost of sales
96,723,000,000 JPY
127,525,000,000 JPY
Ordinary profit (loss)
270,544,000,000 JPY
223,433,000,000 JPY
Gross profit (loss)
445,845,000,000 JPY
418,028,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
339,916,000,000 JPY
326,111,000,000 JPY
Extraordinary income
5,150,000,000 JPY
532,000,000 JPY
Extraordinary losses
21,561,000,000 JPY
5,069,000,000 JPY
Profit (loss) before income taxes
254,133,000,000 JPY
218,896,000,000 JPY
Operating profit (loss)
105,929,000,000 JPY
91,917,000,000 JPY
Non-operating income
Non-operating income
165,666,000,000 JPY
132,197,000,000 JPY
Income taxes - current
35,204,000,000 JPY
5,036,000,000 JPY
Income taxes - deferred
-6,166,000,000 JPY
20,805,000,000 JPY
Non-operating expenses
Interest expenses
571,000,000 JPY
277,000,000 JPY
Non-operating expenses
1,051,000,000 JPY
681,000,000 JPY
Income taxes
29,039,000,000 JPY
25,841,000,000 JPY
Profit (loss)
225,095,000,000 JPY
JPY
JPY
JPY
225,095,000,000 JPY
225,095,000,000 JPY
JPY
JPY
225,095,000,000 JPY
JPY
JPY
JPY
JPY
JPY
193,055,000,000 JPY
JPY
JPY
JPY
JPY
JPY
193,055,000,000 JPY
193,055,000,000 JPY
JPY
193,055,000,000 JPY
JPY
JPY
Extraordinary income
Gain on sale of non-current assets
12,000,000 JPY
11,000,000 JPY
Extraordinary losses
Impairment losses
1,231,000,000 JPY
2,056,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.